In addition, other known USP1 inhibitors, such as pimozide, SJB2-043, and C527, can promote ID1 degradation and inhibit the growth of leukemic cell lines and primary AML patient-derived leukemic cells [80]. This evidence concerns the gene USP1 and acute myeloid leukemia.